Search


 
Results 21 - 30 of about 41 for "FDA update".

New HCV drug combo approved | ACP Gastroenterology ...

The fixed-dose tablet combines the previously approved drugs sofosbuvir and velpatasvir with a new drug, voxilaprevir.

Potency concerns lead to recall of anti-diarrhea drug | ACP ...

Recalled batches of diphenoxylate hydrochloride and atropine sulfate, an adjunctive therapy for the management of diarrhea, were distributed nationwide ...

November 28, 2017 | ACP Gastroenterology Monthly

... stage renal disease. FDA update. Potency concerns lead to recall of anti-diarrhea drug. Recalled batches of diphenoxylate ...

First drug approved to treat thrombocytopenia in adults with ...

Patients who received the drug for five days had increased platelet counts compared to those taking placebo.

Generic form of mesalamine approved | ACP ...

The drug is indicated to induce remission in adults with active, mild to moderate ulcerative colitis and to maintain remission of ulcerative colitis.

June 23, 2017 | ACP Gastroenterology Monthly

... patients with irritable bowel syndrome. FDA update. Generic form of mesalamine approved. The drug is indicated to induce ...

March 23, 2018 | ACP Gastroenterology Monthly

... mothers with chronic HBV. FDA update. FDA sends warning to duodenoscope manufacturers. The manufacturers have not ...

Proton-pump inhibitor recalled | ACP Gastroenterology ...

One lot of pantoprazole sodium for injection (40 mg per vial) was recalled in December.

January 27, 2017 | ACP Gastroenterology Monthly

... IBS after infectious enteritis. FDA update. Drug for chronic idiopathic constipation approved. The oral medication is taken ...

May 26, 2017 | ACP Gastroenterology Monthly

... and case examples. FDA update. Regorafenib now FDA-approved to treat hepatocellular carcinoma. Approved use of the ...

Result Page: < Previous  1 2 3 4 5  Next >